Neuroplasticity after stroke is not automatic
Lyophilized peptide powders require bacteriostatic water reconstitution and sterile technique
Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
Dictionary of Medicine
TB-500 receives attention for cellular migration, connective tissue remodeling, and regenerative physiology